IGM Biosciences (NASDAQ:IGMS) Target Raised by Stifel Nicolaus to $95.00

0
26

IGM Biosciences stock has undergone multiple analysts rating changes in the recent past.  IGM Biosciences stock Target Raised by   Stifel Nicolaus on 6/30/2020. In a note to investors, the firm issued a new target price of $95.00. The analysts previously had $67.00 target price. Stifel Nicolaus’s price target would indicate a potential upside of 39.83% from the stock’s previous close.

Shares of IGM Biosciences traded up $3.46 on Tuesday, reaching $71.40. 35937 shares of the stock traded hands, compared to its average volume of 120371. Shares of were trading at $71.40 on Tuesday. The firm’s 50 day moving average is $$61.33 and its 200 day moving average is .IGM Biosciences  has a 12 month low of $67.92 and a 12 month high of $80.55. While on yearly highs and lows, IGM Biosciences today has traded high as $71.40 and has touched $67.92 on the downward trend.

IGM Biosciences Earnings and What to expect: 

IGM Biosciences last announced its earnings data on May 7th, 2020. The reported ($0.58) earnings per share for the quarter, missing the consensus estimate of ($0.55) by $0.03. IGM Biosciences has generated ($4.80) earnings per share over the last year. IGM Biosciences has not formally confirmed its next earnings publication date, but the company’s estimated earnings date is Thursday, August 6th, 2020 based off prior year’s report dates.

Latest Insiders Trading and Volume : 

  • Insider Ownership Percentage: 79.34%
  • On 12/9/2019 Director M Kathleen Behrens Buy 20,000 at average share price of $24.87 which equates to $497,400.00 in money value.
  • On 9/24/2019 Director Jakob Haldor Topsoe Buy 4,000 at average price of  $20.50 with total value of : Not Data Available
  • On 9/20/2019 Director Bros. Advisors Lp Baker Buy 3,144,000 at average price of  $16.00 with total value of : $50,304,000.00
  • See More Analyst Rating at: RATING

Other Analyst’s rating for IGM Biosciences

  • 5/28/2020 – IGM Biosciences is now covered by analysts at SunTrust Banks, Inc.. They set a “buy” rating and a $86.00 price target on the stock.
  • 5/8/2020 – IGM Biosciences had its price target raised by analysts at Stifel Nicolaus from $60.00 to $67.00. They now have a “buy” rating on the stock.
  • 5/8/2020 – IGM Biosciences had its price target raised by analysts at Piper Sandler from $53.00 to $81.00. They now have an “overweight” rating on the stock.
  • 4/21/2020 – IGM Biosciences is now covered by analysts at Wedbush. They set an “outperform” rating on the stock.
  • See More Analyst Rating at: RATING

Other rating updates by Stifel Nicolaus: 

  • 6/30/2020 – Archer Daniels Midland had its price target lowered by analysts at Stifel Nicolaus from $48.00 to $47.00. They now have a “buy” rating on the stock.
  • 6/30/2020 – Atlas Air Worldwide had its price target raised by analysts at Stifel Nicolaus from $50.00 to $51.00. They now have a “buy” rating on the stock.
  • 6/30/2020 – Boston Properties had its price target lowered by analysts at Stifel Nicolaus from $115.00 to $110.00. They now have a “buy” rating on the stock.
  • 6/30/2020 – Harsco had its price target raised by analysts at Stifel Nicolaus from $16.00 to $20.00. They now have a “buy” rating on the stock.
  • See More Analyst Rating at: RATING

IGM Biosciences (NASDAQ:IGMS) Moving Average Technical Analysis

5 day Moving Average is $$71.06 And 5 day price change is -$3.95 (-5.47%)  with average volume for 5 day average is 155,657. While technical analysis for average 20 days shows significant difference, 20 day moving average is  $66.02 and 20 day price change is $5.25 (8.33%) and average 20 day moving volume is 128,389. 50 day moving average is $61.33  and 50 day price change is $9.74 ( 16.64%)  and with average volume for 50 days is : 95,268. 200 day moving average is   and 200 day price change is ()  and with average volume for 200 days is : .

See More Analyst Rating at: RATING